The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature
Open accessAbstract
Background. Laboratory data suggests a reduction of Faecalibacterium prausnitzii(F. prausnitzii) is confirmed both in fecal samples in inflammatory bowel disease (IBD) patients. Numerous observational studies have suspected dysbiosis, an imbalance between protective and harmful bacteria to be relevant to the etiology and pathogenesis of IBD.Methods. Medline, EMBASE, Pubmed, and others. were searched by 2 independent reviewers. Of 48 abstracts reviewed, 11 studies met our inclusion criteria (subjectN=1180). Meta-analysis was performed with Review Manager 5.2.Results. The bacterial count of F. prausnitzii in IBD patients was significantly lower (6.7888±1.8875) log10 CFU/g feces than healthy controls (7.5791±1.5812) log10 CFU/g feces;P<0.0001. The Standardization Mean Difference of F. prausnitzii in IBD patients was −0.94 (95% confidence interval [CI]: −1.07–−0.80). Subgroup analyses revealed a trend toward a greater effect for CD (SMD: −1.13, 95% CI: −1.32–−0.94) when compared to UC (SMD: −0.78, 95% CI: −0.97–−0.60).Conclusions. The abundance of F. prausnitzii was decreased in IBD patients compared with healthy controls. Furthermore, the reduction of F. prausnitzii and misbalance of the intestinal microbiota are particularly higher in CD patients with ileal involvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The Microbiota in Inflammatory Bowel Disease in Different Age Groups
Cucchiara, S., Iebba, V., Conte, M. P., & Schippa, S. (2009) · Digestive Diseases · doi:10.1159/000228558 · Cited by 69
RetractedEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Faecalibacterium prausnitzii and human intestinal health
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L., Chatel, J., Sokol, H., Thomas, M., Wells, J., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.003 · Cited by 1,228
Duncan, S. H., Louis, P., & Flint, H. J. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.5810-5817.2004 · Cited by 1,129
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Modulation of natural killer cell activity by viruses
Lisnić, V. J., Krmpotić, A., & Jonjić, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.011 · Cited by 1,003
Ashelford, K. E., Chuzhanova, N. A., Fry, J. C., Jones, A. J., & Weightman, A. J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.7724-7736.2005 · Cited by 795
Walker, A. W., Sanderson, J. D., Churcher, C., Parkes, G. C., Hudspith, B. N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 726
Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01500-13 · Cited by 509
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
Chassaing, B., & Darfeuille–Michaud, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.054 · Cited by 443 · cited 1×
“In patients with inflammatory bowel diseases (IBD), the composition and diversity of the microbiota are always altered [3].”
BackgroundMacfarlane, G. T., & Macfarlane, S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822fecfe · Cited by 406
Angelberger, S., Reinisch, W., Makristathis, A., Lichtenberger, C., Dejaco, C., Papay, P., Novacek, G., Trauner, M., Loy, A., & Berry, D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.257 · Cited by 330 · cited 3×
“Only provided data for pediatric patients: 2 [24, 28] Animal studies: 2 [26, 27] 11 studies included [1, 21–23, 25, 29–35]”
BackgroundPackey, C. D., & Sartor, R. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a8a5d · Cited by 319
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease
Fujimoto, T., Imaeda, H., Takahashi, K., Kasumi, E., Bamba, S., Fujiyama, Y., & Andoh, A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12073 · Cited by 304
Hansen, R., Russell, R. K., Reiff, C., Louis, P., McIntosh, F., Berry, S. H., Mukhopadhya, I., Bisset, M. W., Barclay, A. R., Bishop, J., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.335 · Cited by 288
Qiu, X., Zhang, M., Yang, X., Hong, N., & Yu, C. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.04.002 · Cited by 286
Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M., & Doerffel, Y. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20330 · Cited by 276
Highlighting new phylogenetic specificities of Crohnʼs disease microbiota
Mondot, S., Kang, S., Furet, J. P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Doré, J., & Leclerc, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21436 · Cited by 264
Martinez-Medina, M., Aldeguer, X., Gonzalez-Huix, F., Acero, D., & Garcia-Gil, J. L. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235828.09305.0c · Cited by 263
Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., & Antolin, M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12365 · Cited by 249
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Prescott, N. J., Pessoa-Lopes, P., Mathew, C. G., Sanderson, J., Hart, A. L., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21864 · Cited by 221
Luther, J., Dave, M., Higgins, P. D. R., & Kao, J. Y. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21116 · Cited by 220
Benus, R. F. J., van der Werf, T. S., Welling, G. W., Judd, P. A., Taylor, M. A., Harmsen, H. J. M., & Whelan, K. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001030 · Cited by 210
Maccaferri, S., Vitali, B., Klinder, A., Kolida, S., Ndagijimana, M., Laghi, L., Calanni, F., Brigidi, P., Gibson, G. R., & Costabile, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq345 · Cited by 186
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease
Andoh, A., Kuzuoka, H., Tsujikawa, T., Nakamura, S., Hirai, F., Suzuki, Y., Matsui, T., Fujiyama, Y., & Matsumoto, T. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0605-0 · Cited by 163
Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers
Himmel, M. E., Yao, Y. F., Orban, P. C., Steiner, T. S., & Levings, M. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03572.x · Cited by 146
Vermeiren, J., den Abbeele, P. V., Laukens, D., Vigsnæs, L. K., Vos, M. D., Boon, N., & de Wiele, T. V. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2011.01252.x · Cited by 140
McLaughlin, S. D., Walker, A. W., Churcher, C., Clark, S. K., Tekkis, P. P., Johnson, M. W., Parkhill, J., Ciclitira, P. J., Dougan, G., Nicholls, R. J., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181e3dc8b · Cited by 114
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
Jia, W., Whitehead, R. N., Griffiths, L., Dawson, C., Waring, R. H., Ramsden, D. B., Hunter, J. O., & Cole, J. A. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02057.x · Cited by 112
Prideaux, L., Kang, S., Wagner, J., Buckley, M. J., Mahar, J. E., Cruz, P. P. D., Wen, Z., Chen, L., Xia, B., van Langenberg, D. R., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435759.05577.12 · Cited by 110
Wang, M., Molin, G., Ahrné, S., Adawi, D., & Jeppsson, B. W. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9461-1 · Cited by 59
Dörffel, Y., Swidsinski, A. V., Loening-Baucke, V. A., Wiedenmann, B., & Pavel, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21923 · Cited by 45
Faecalibacterium prausnitzii and Crohn’s Disease – is There any Connection?
Gałęcka, M., Szachta, P., Bartnicka, A., Łykowska‐Szuber, L., Eder, P., & Schwiertz, A. (2013) · Polish Journal of Microbiology · doi:10.33073/pjm-2013-013 · Cited by 24
Siaw, Y. H., & Hart, A. L. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12404 · Cited by 7
The more the merrier: Faecalibacterium prausnitzii in C rohn's disease
O'Brien, C. L., Allison, G. E., & Pavli, P. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12153 · Cited by 5
Cited by
The Intestinal Microbiome in Early Life: Health and Disease
Arrieta, M.-C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M., & Finlay, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00427 · Cited by 1,024
Dietary fibre in gastrointestinal health and disease
Gill, S. K., Rossi, M., Bajka, B., & Whelan, K. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00375-4 · Cited by 979
Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses
Piovani, D., Danese, S., Peyrin-Biroulet, L., Nikolopoulos, G. K., Lytras, T., & Bonovas, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.016 · Cited by 784
Faecalibacterium: a bacterial genus with promising human health applications
Martín, R., Rios-Covian, D., Huillet, E., Auger, S., Khazaal, S., Bermúdez-Humarán, L. G., Sokol, H., Chatel, J.-M., & Langella, P. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad039 · Cited by 566
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
Metadata
- Authors
- Cao, Y., Shen, J., & Ran, Z. H.
- Venue
- Gastroenterology Research and Practice
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-7
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- OpenAlex
- W2083999893
- Cited by
- 302
- References
- 41
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.